Neurochemical Research

, Volume 43, Issue 10, pp 2000–2007 | Cite as

RASgrf1, a Potential Methylatic Mediator of Anti-epileptogenesis?

  • Yi Bao
  • Xiaoni Chen
  • Liang WangEmail author
  • Jixiu Zhou
  • Xinwei Fu
  • Xuefeng Wang
  • Zheng XiaoEmail author
Original Paper


Epileptogenesis, induced by status epilepticus (SE), is a chronic process, and intervention in this progress may prevent chronic epilepsy. It has been proposed that DNA methylation might be related with epileptogenesis. RASgrf1 has a differentially methylated region at the promoter which can silence gene expression. We have previously observed the down-regulation of RASgrf1 in epilepsy patients and proved that hypermethylation of RASgrf1 reaches maximal level at the latent period in mice after kainate-induced SE (KA mice), with corresponding alteration of RASgrf1 expression. In the present study, N-phthalyl-L-tryptophan (RG108), a DNA methyltransferase inhibitor, was applied in KA mice at latent phase and the behavior, electroencephalogram and pathological changes were observed in chronic phase. Methylation and expression of RASgrf1 were determined by polymerase chain reaction (PCR), western blotting, and bisulfite sequencing PCR. The results showed that the incidence of spontaneous recurrent seizures (SRS) was significantly lower in the RG108 group than the normal saline (NS) group. Subgroup analysis showed significant hypermethylation and lower expression of RASgrf1 in the RG108–SRS subgroup and the NS–SRS subgroup but not in the RG108–NSRS (no SRS) subgroup and the NS–NSRS subgroup compared with the control group. No significant difference was found between the RG108–SRS and NS–SRS subgroups. Meanwhile, hippocampal neuronal loss was observed in RG108–SRS and NS–SRS subgroups. We thus demonstrated that RG108 could modify the progression of epileptogenesis after KA induced SE and prevent chronic epilepsy. Meanwhile, hypermethylation of RASgrf1 after KA induced SE could be reversed with corresponding changes of RASgrf1 expression. Additionally, we speculated that RASgrf1 might be a potential epigenetic mediator in epileptogenesis and chronic epilepsy.


RASgrf1 DNA methylation RG108 Epilepsy Epileptogenesis 



This work was supported by the National Natural Science Foundation of China (Grant Numbers 81071040, 81471320).

Compliance with Ethical Standards

Conflict of interest

None of the authors has any conflicts of interest to disclose.


  1. 1.
    Brodie MJ (2016) Pharmacological treatment of drug-resistant epilepsy in adults: a practical guide. Curr Neurol Neurosci Rep 16(9):82CrossRefGoogle Scholar
  2. 2.
    Pitkanen A, Lukasiuk K (2011) Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 10(2):173–186CrossRefGoogle Scholar
  3. 3.
    Goldberg EM, Coulter DA (2013) Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat Rev Neurosci 14(5):337–349CrossRefGoogle Scholar
  4. 4.
    Younus I, Reddy DS (2017) Epigenetic interventions for epileptogenesis: a new frontier for curing epilepsy. Pharmacol Ther 177:108–122CrossRefGoogle Scholar
  5. 5.
    Hwang JY, Aromolaran KA, Zukin RS (2013) Epigenetic mechanisms in stroke and epilepsy. Neuropsychopharmacology 38(1):167–182CrossRefGoogle Scholar
  6. 6.
    Kobow K, Blumcke I (2012) The emerging role of DNA methylation in epileptogenesis. Epilepsia 53(Suppl 9):11–20CrossRefGoogle Scholar
  7. 7.
    Henshall DC, Kobow K (2015) Epigenetics and epilepsy. Cold Spring Harb Perspect Med. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Wang L et al (2016) DNA methylation profiling reveals correlation of differential methylation patterns with gene expression in human epilepsy. J Mol Neurosci 59(1):68–77CrossRefGoogle Scholar
  9. 9.
    Miller-Delaney SF et al (2015) Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy. Brain 138(Pt 3):616–631CrossRefGoogle Scholar
  10. 10.
    Kobow K et al (2013) Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathol 126(5):741–756CrossRefGoogle Scholar
  11. 11.
    Miller-Delaney SF et al (2012) Differential DNA methylation patterns define status epilepticus and epileptic tolerance. J Neurosci 32(5):1577–1588CrossRefGoogle Scholar
  12. 12.
    Krapivinsky G et al (2003) The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RASgrf1. Neuron 40(4):775–784CrossRefGoogle Scholar
  13. 13.
    Zhu Q et al (2013) Decreased expression of Ras-GRF1 in the brain tissue of the intractable epilepsy patients and experimental rats. Brain Res 1493:99–109CrossRefGoogle Scholar
  14. 14.
    Chen X et al (2017) Association of RASgrf1 methylation with epileptic seizures. Oncotarget 8(28):46286–46297PubMedPubMedCentralGoogle Scholar
  15. 15.
    Stafstrom CE, Thompson JL, Holmes GL (1992) Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures. Brain Res Dev Brain Res 65(2):227–236CrossRefGoogle Scholar
  16. 16.
    Yang Y et al (2017) Chronic metformin treatment facilitates seizure termination. Biochem Biophys Res Commun 484(2):450–455CrossRefGoogle Scholar
  17. 17.
    Hauser RM, Henshall DC, Lubin FD (2017) The epigenetics of epilepsy and its progression. Neuroscientist. CrossRefPubMedGoogle Scholar
  18. 18.
    Beghi E (2003) Overview of studies to prevent posttraumatic epilepsy. Epilepsia 44(Suppl 10):21–26CrossRefGoogle Scholar
  19. 19.
    Williams-Karnesky RL et al (2013) Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. J Clin Invest 123(8):3552–3563CrossRefGoogle Scholar
  20. 20.
    Zhu Q et al (2012) Increased expression of DNA methyltransferase 1 and 3a in human temporal lobe epilepsy. J Mol Neurosci 46(2):420–426CrossRefGoogle Scholar
  21. 21.
    Nelson ED, Kavalali ET, Monteggia LM (2008) Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J Neurosci 28(2):395–406CrossRefGoogle Scholar
  22. 22.
    Levenson JM et al (2006) Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem 281(23):15763–15773CrossRefGoogle Scholar
  23. 23.
    Machnes ZM et al (2013) DNA methylation mediates persistent epileptiform activity in vitro and in vivo. PLoS ONE 8(10):e76299CrossRefGoogle Scholar
  24. 24.
    Zippel R et al (1997) Ras-GRF, the activator of Ras, is expressed preferentially in mature neurons of the central nervous system. Brain Res Mol Brain Res 48(1):140–144CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of NeurologyThe First Affiliated Hospital of Chongqing Medical UniversityChongqingChina
  2. 2.Department of NeurologyXi’an No.3 HospitalXianChina
  3. 3.Department of NeurologyThe People’s Hospital of Rongchang DistrictChongqingChina
  4. 4.Department of NeurologyThe Third Hospital of MianyangMianyangChina

Personalised recommendations